Adaptive closed-loop control provides blood-glucose regulation using dual subcutaneous insulin and glucagon infusion in diabetic swine

Journal of Diabetes Science and Technology

Volumn 1, Issue 2, 2007, Pages 181-192

  El Khatib, Firas H ^a   Jiang, John ^a   Damiano, Edward R ^a  

^a Boston University   (United States)

Author keywords

Counterregulatory hormone; Hyperglycemia; Hypoglycemia; In vivo; Infusion pump; Predictive control; Swine

Indexed keywords

EID: 84887257430     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680700100208     Document Type: Article

References (43)

1. The Diabetes Control and Complications Trial research Group (DCCT). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med. 1993 Sep. 30;329(14):977-86.
2. Eiselein L, Shcwartz HJ, Rutledge JC. The challenge of type 1 diabetes mellitus. LAR J. 2004;45(3):231-6.
3. Reckless J. Diabetes and cardiovascular disease: impacts from the NSF and GMS. Diabetes Primary Care. 2004;6:134-9.
4. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005 Dec. 22;353(25):2643-53.
5. Jaremko J, Rorstad O. Advances toward the implantable artificial pancreas for treatment of diabetes. Diabetes Care 1998 Mar; 21(3):444-50.
6. Clemens AH. Feedback control dynamics for glucose controlled insulin infusion systems. Med Prog Technol. 1979;6:91-8.
7. Bellomo G, Brunetti P, Calabrese G, Mazzotti D, Sarti E, Vincenzi A. Optimal feedback glycaemia regulation in diabetics. Med Biol Eng Comp. 1982 May; 20(3):329-35.
8. Brunetti P, Cobelli C, Cruciani P, Fabietti PG, Filippucci F, Santeusanio F. A simulation study on a self-tuning portable controller of blood glucose. Int J Artif Org. 1993;16:51-7.
9. Marliss EB, Murray FT, Stokes EF, Zinman B, Nakhooda AF, Denoga A, Leibel BS, Albisser AM. Normalization of glycemia in diabetes during meals with insulin and glucagon delivery by the artificial pancreas. Diabetes. 1977 Jul; 26(7):663-72.
10. Pagurek D, Riordon JS, Mahmound S. Adaptive control of the human glucose regulatory system. Med Biol Eng. 1972 Nov; 10(6):752-61.
11. Parker RS, Doyle FJ III, Peppas NA. A model-based algorithm for blood glucose control in type I diabetic patients. IEEE Trans Biomed Eng. 1999 Feb; 46(2):148-57.
12. Parker RS, Doyle FJ III, Peppas NA. The intravenous route to blood glucose control. IEEE Eng Med Biol. 2001 Jan-Feb; 20(1):65-73.
13. Shichiri M, Kawamori R, Hakui N, Yamasaki Y, Abe H. Closedloop glycemic control with a wearable artificial endocrine pancreas. Variations in daily insulin requirements to glycemic response. Diabetes. 1984 Dec; 33(12):1200-2.
14. Albisser AM, Leibel BS, Ewart TG, Davidovac Z, Botz CK, Zingg W. An artificial endocrine pancreas. Diabetes. 1974 May; 23(5):389-96.
15. Botz CK. An improved control algorithm for an artificial beta cell. IEEE Trans Biomed Eng. 1976 May; 23(3):252-5.
16. Candas B, Radziuk J. An adaptive plasma glucose controller based on a nonlinear insulin/glucose model. IEEE Trans Biomed Eng. 1994 Feb; 41(2):116-24.
17. Renard E. Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy. Curr Opin Pharmacol. 2002 Dec; 2(6):708-16.
18. El-Khatib FH, Jiang J, Gerrity RG, Damiano ER. Pharmacodynamics and stability of subcutaneously infused glucagon in a type 1 diabetic swine model in vivo. Diabetes Technol Ther. 2007;9(2):135-144.
19. Haymond MW, Schreiner B. Mini-dose glucagon rescue for hypoglycemia in children in type 1 diabetes. Diabetes Care. 2001 Apr; 24(4):643-5.
20. Gerich GE, Langlois M, Noacco C, Karam J, ForSham PH. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science. 1973 Oct. 12;182(108):171-3.
21. Gerrity RG, Natarajan R, Nadler JL, Kimsey T. Diabetes-induced accelerated atherosclerosis in swine. Diabetes. 2001 Jul; 50(7):1654-65.
22. Plum A, Agerso H, Andersen L. Pharmacokinetics of the rapidacting insulin analog, insulin aspart, in rats, dogs, and pigs, and pharmacodynamics of insulin aspart in pigs. Drug Metab Dispos. 2000 Feb; 28(2):155-60.
23. Clarke DW, Mohtadi C, Tuffs PS. Generalized predictive control-Part I. The basic algorithm. Automatica. 1987;23:137-48.
24. Comacho EF, BorDons C. Model predictive control. London: Springer; 2004. p. 47-57.
25. Garcia CE, Prett DM, Morari M. Model predictive control: theory and practice-A survey. Automatica. 1989;25:335-48.
26. Femat R, Velazquez ER. Blood glucose regulation: an output feedback approach. Proc IEEE Inti Conf Control App. 1999;1:1290-3.
27. Fisher ME, Teo KL. Optimal insulin infusion resulting from a mathematical model of blood glucose dynamics. IEEE Trans Biomed Eng. 1989;36:479-86.
28. Kan S, Onodera H, Furutani E, Aung T, Araki M, Nishimura H, Maetani S, Imamura M. Novel control system for blood glucose using a model predictive method. ASAIO J. 2000 Nov-Dec; 46(6):657-62.29.
29. Balkin M, Mascioli C, Smith V, Alnachawati H, Mehrishi S, Saydain G, Slone H, Alessandrini J, Brown L. Achieving durable glucose control in the intensive care unit without hypoglycemia: a new practical IV insulin protocol. Diabetes Metab Res Rev. 2007 Jan; 23(1):49-55.
30. Van Den Berghe GH, Wouters PJ, Weekers F. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-67.
31. Quinn JA, Snyder SL, Berghoff JL, Colombo CS, Jacobi J. A practical approach to hyperglycemia management in the intensive care unit: evaluation of an intensive insulin infusion protocol. Pharmacotherapy. 2006 0ct; 26(10):1410-20.
32. Astrom KJ, Wittenmark B. On self-tuning regulators. Automatica. 1973;9:195-9
33. Clarke DW, Gawthrop PJ. Self-tuning control. Proc IEE 1979;126(6):633-40.
34. El-Khatib FH. System identification and adaptive dosed-loop glucose control in a type 1 diabetic swine model [dissertation]. Champaign (IL): University of Illinois at Urbana-Champaign; 2005.
35. Fischer U, Schenk W, Salzsieder E, Albrecht G, Abel P, Freyse EJ. Does physiological blood glucose control require an adaptive control strategy? IEEE Trans Biomed Eng. 1987 Aug; 34(8):575-82.
36. Lai TL, Wei CZ. Extended least squares and their applications to adaptive control and prediction in linear systems. IEEE Trans Auto Control. 1986; AC-31(10):898-906.
37. Ljung L. System identification: theory for the user. Upper Saddle River, NJ: Prentice Hall; 1999.
38. Comacho E F, Bordons C. Model predictive control. London: Springer-Verlag; 1979. p. 47-57.
39. Clarke DW, Mohtadi C, Tuffs PS. Generalized predictive control-Part I. The basic algorithm. Automatica. 1987;23(2):137-48.
40. Garcia CE, Prett D M, Morari M. Model predictive control: theory and practice-a survey. Automatica. 1989;25(3):335-48.
41. Guo L. Further results on least squares based adaptive minimum variance control. SIAM J Control Optim. 1994;32(1):187-212.
42. Noble SL, Johnston E, Walton B. Insulin lispro: a fast-acting insulin analog. Am Fam Physician. 1998 Jan 15;57(2):279-86, 289-92.
43. El-Khatib FH, Jiang J, Gerrity RG, Damiano ER. Pharmacodynamics and stability of subcutaneously infused glucagon in a type 1 diabetic swine model in vivo. Diabetes Technol Ther. 2007;9(2):135-144.